ID

15600

Descripción

The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00819247

Link

https://clinicaltrials.gov/show/NCT00819247

Palabras clave

Versiones (1)
  1. 4/6/16 4/6/16 -
Subido en

4 de junio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00819247

Inglés

Eligibility Prostate Cancer NCT00819247

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed informed consent before any trial related activity
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
proven prostate cancer with a need for endocrine treatment
Descripción

prostate cancer with a need for endocrine treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0038900
testosterone level within the normal range for the age
Descripción

testosterone level

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0039601
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous or current hormonal treatment of prostate cancer
Descripción

hormonal treatment of prostate cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0600139
candidate for prostatectomy or radiotherapy
Descripción

prostatectomy or radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0033573
UMLS CUI [1,2]
C1548635
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C1548635
history of severe asthma, anaphylactic reactions or quincke's oedema
Descripción

severe asthma or anaphylactic reactions or quinckes oedema

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0581126
UMLS CUI [2]
C0002792
UMLS CUI [3]
C0002994
hypersensitivity towards any component of fe200486
Descripción

hypersensitivity towards fe200486

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0971731
cancer disease within the last ten years except for prostate cancer and some skin cancers
Descripción

other malignancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
presenting with significant neurological, gastrointestinal, renal, hepatic, cardiovascular, psychological, pulmonary, metabolic, endocrine, haematological, dermatological or infectious disorder. in addition any other condition such as excessive alcohol or drug abuse that may interfere with trial participation or influence the conclusion of the trial as judged by the investigator
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
mental incapacity or language barrier
Descripción

mental incapacity or language barrier

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
UMLS CUI [2]
C0237167
having received an investigational product within the last 12 weeks preceding the trial
Descripción

investigational product

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
previous participation in this trial
Descripción

previous participation in this trial

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00819247

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
signed informed consent before any trial related activity
boolean
C0021430 (UMLS CUI [1])
prostate cancer with a need for endocrine treatment
Item
proven prostate cancer with a need for endocrine treatment
boolean
C0600139 (UMLS CUI [1,1])
C0038900 (UMLS CUI [1,2])
testosterone level
Item
testosterone level within the normal range for the age
boolean
C0039601 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
hormonal treatment of prostate cancer
Item
previous or current hormonal treatment of prostate cancer
boolean
C0279025 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
prostatectomy or radiotherapy
Item
candidate for prostatectomy or radiotherapy
boolean
C0033573 (UMLS CUI [1,1])
C1548635 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1548635 (UMLS CUI [2,2])
severe asthma or anaphylactic reactions or quinckes oedema
Item
history of severe asthma, anaphylactic reactions or quincke's oedema
boolean
C0581126 (UMLS CUI [1])
C0002792 (UMLS CUI [2])
C0002994 (UMLS CUI [3])
hypersensitivity towards fe200486
Item
hypersensitivity towards any component of fe200486
boolean
C0020517 (UMLS CUI [1,1])
C0971731 (UMLS CUI [1,2])
other malignancy
Item
cancer disease within the last ten years except for prostate cancer and some skin cancers
boolean
C0006826 (UMLS CUI [1])
comorbidity
Item
presenting with significant neurological, gastrointestinal, renal, hepatic, cardiovascular, psychological, pulmonary, metabolic, endocrine, haematological, dermatological or infectious disorder. in addition any other condition such as excessive alcohol or drug abuse that may interfere with trial participation or influence the conclusion of the trial as judged by the investigator
boolean
C0009488 (UMLS CUI [1])
mental incapacity or language barrier
Item
mental incapacity or language barrier
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0237167 (UMLS CUI [2])
investigational product
Item
having received an investigational product within the last 12 weeks preceding the trial
boolean
C2348568 (UMLS CUI [1])
previous participation in this trial
Item
previous participation in this trial
boolean
C2348568 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial